Table 3.
Estimated frequencies of symptoms among patients with COVID-19.
| Total |
Group I |
Group II |
Group III |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. of studies | No. of patients | Estimated frequency (95% CI) | No. of studies | No. of patients | Estimated frequency (95% CI) | No. of studies | No. of patients | Estimated frequency (95% CI) | No. of studies | No. of patients | Estimated frequency (95% CI) | |
| Fever | 13 | 2377 | 82.46% (69.62–95.30) | 3 | 278 | 93.39% (84.25–102.53) | 3 | 1356 | 72.10% (38.02–106.18) | 7 | 743 | 82.64% (76.45–88.71) |
| Cough | 13 | 2377 | 62.36% (55.67–69.05) | 3 | 278 | 72.14% (57.05–87.23) | 3 | 1356 | 63.92% (51.58–76.26) | 7 | 743 | 57.36% (47.38–67.33) |
| Dyspnea | 10 | 2145 | 21.06% (13.41–28.71) | 3 | 278 | 37.18% (25.69–48.67) | 3 | 1356 | 24.12% (14.77–33.47) | 4 | 511 | 6.16% (1.38–10.95) |
| Myalgia | 7 | 1705 | 20.10% (12.08–28.11) | 2 | 237 | 22.84% (−0.38-46.07) | 1 | 1099 | 14.90% (12.74–17.06) | 4 | 369 | 20.82% (3.82–37.83) |
| Fatigue | 6 | 1759 | 41.11% (25.08–57.13) | 1 | 138 | 69.60% (61.96–77.24) | 2 | 1219 | 56.37% (20.21–92.53) | 3 | 402 | 22.44% (16.63–28.25) |
| Headache | 12 | 2254 | 10.05% (6.72–13.39) | 3 | 275 | 7.17% (3.93–10.42) | 2 | 1236 | 12.25% (8.48–16.03) | 7 | 856 | 11.13% (5.87–16.39) |
| Sore throat | 8 | 1755 | 12.71% (8.95–16.47) | 2 | 237 | 11.09 (−0.96–23.14) | 1 | 1099 | 13.90% (11.94–15.86) | 5 | 419 | 13.32% (7.40–19.23) |
| Expectoration | 8 | 1764 | 26.09% (14.68–37.51) | 2 | 177 | 27.11% (20.69–33.52) | 2 | 1236 | 19.08% (−9.64–47.79) | 4 | 351 | 29.21% (12.76–45.67) |
| Diarrhea | 10 | 2000 | 6.25% (4.06–8.44) | 3 | 164 | 2.12% (−1.23–5.46) | 3 | 1375 | 7.68% (2.32–13.04) | 4 | 351 | 6.60% (3.74–9.45) |
CI, confidence interval.